Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy.

Background: The aim of the study was to investigate a series of complete blood cell count-based biomarkers of systemic inflammation as predictors of clinical outcomes in patients who underwent first-line chemoimmunotherapy for advanced NSCLC. Methods: Consecutive patients with pathologically diagnos...

Descripción completa

Detalles Bibliográficos

Publicado en:	Current Oncology Vol. 31; no. 9; pp. 4955 - 4968
Autores principales:	Putzu, Carlo, Serra, Riccardo, Campus, Rachele, Fadda, Giovanni Maria, Sini, Claudio, Marongiu, Andrea, Ginesu, Giorgio Carlo, Fois, Alessandro Giuseppe, Palmieri, Giuseppe, Zinellu, Angelo, Cossu, Antonio, Paliogiannis, Panagiotis
Formato:	Journal Article
Publicado:	MDPI Sep2024
Acceso en línea:	Ver este registro en EBSCOhost